Tech Company Financing Transactions
Complement 1 Funding Round
Complement 1 closed a $16 million Seed investment round on 5/13/2025. Backers included Blume Ventures, Owl Ventures and private investors.
Transaction Overview
Company Name
Announced On
5/13/2025
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Seed
Investors
Blume Ventures (Lead Investor)
Owl Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
8, The Green, County of Kent A
Dover, DE 19901
USA
Dover, DE 19901
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission is simple: to transform cancer outcomes through evidence-based lifestyle interventions that actually stick. Complement 1 is redefining cancer care with the first clinically validated, daily 1:1 lifestyle modification program designed specifically for patients in treatment, survivors, and those at high risk.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Karan Bajaj
Chief Marketing Officer
Katya Bykova
Chief Operating Officer
Trupti Mukker
VP - Bus. Development
Dina Segro
Browse more venture capital transactions:
Prev: 5/13/2025: Commonwealth Fusion Systems venture capital transaction
Next: 5/13/2025: Remedy Plan Therapeutics venture capital transaction
Share this article
About Our VC Transactions Data
We report on all VC transactions involving tech companies. All VC database entries reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs